Woodside Energy Group Ltd
WDS
Origin Energy Ltd
ORG
National Australia Bank Ltd
NAB
Telstra Group Ltd
TLS
ANZ Group Holdings Ltd
ANZ
AU Stock MarketDetailed Quotes
IMU Imugene Ltd
- 0.036
- -0.001-2.70%
20min DelayMarket Closed Dec 24 14:10 AET
272.41MMarket Cap-1.71P/E (Static)
0.037High0.036Low5.62MVolume0.037Open0.037Pre Close205.91KTurnover0.13052wk High0.09%Turnover Ratio7.57BShares0.03552wk Low-0.021EPS TTM225.10MFloat Cap38.521Historical HighLossP/E (Static)6.25BShs Float0.004Historical Low-0.021EPS LYR2.70%Amplitude--Dividend TTM2.25P/B1Lot Size--Div YieldTTM
Imugene Ltd News
Imugene Ltd: Azer-cel Accepted for Presentation at ASTCT Tandem Meetings
Imugene Ltd: Imugene Confirms Pending Receipt of c.$11m R&D Tax Refund
Imugene Ltd: onCARlytics Trial Doses First Patient in IT Combination Arm
Imugene Ltd: Imugene Opens First Australian Site for azer-cel Trial
Imugene Ltd: Complete Response in MAST Study Maintained Over Two Years
Imugene Ltd: Imugene Receives Orphan Drug Designation for VAXINIA
Imugene Ltd: Imugene Webinar - Azer-cel Trial Update
Imugene Ltd: Three Complete Responses in Azer-Cel Phase 1b Trial
Imugene Ltd: Imugene ESG Report 2024
Imugene Ltd: Corporate Governance Statement 2024 and Appendix 4G
Imugene Ltd: Release of Shares from Voluntary Escrow
Imugene Ltd: Quarterly Activities/Appendix 4C Cash Flow Report
Imugene Ltd: First patient dosed in Phase 1 bile tract cancer trial
Imugene Ltd: Change of Director's Interest Notice x6
Imugene Ltd: Imugene onCARlytics Doses First Patient in IV Combination
Imugene Ltd: Quarterly Activities/Appendix 4C Cash Flow Report
Imugene Ltd: Change of Director's Interest Notice - PH
Imugene Ltd: Imugene & Kincell Bio Strategic Partnership Investor Webinar
Imugene Ltd: Imugene and Kincell Bio Announce Strategic Partnership
Imugene Ltd: Bile Tract Cancer Study Opens after MAST High Dose Clearance
